Design Therapeutics Inc
DSGN
$11.97-3.62%
End of day · as of Oct 7, 2026, 5:15 AM ET
Mkt cap
$214.02M
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
N/A
EPS (TTM)
$-1.18
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
1.62
Div yield
N/A
Sector
Healthcare
Design Therapeutics Inc (DSGN) is a biotechnology company listed on US.
Latest reported DSGN revenue for 2025-12-31 was $0. Net income was -$69.8M. DSGN currently screens at market cap $214.0M.
Use this DSGN research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full DSGN income, balance, and cash tables.
Design Therapeutics Inc (DSGN) is a biotechnology company in the Healthcare sector.
Latest cached Design Therapeutics Inc (DSGN) net income for Dec 31, 2025 was -$69.8M. Statements: https://lician.com/financials/dsgn
Design Therapeutics Inc (DSGN) market capitalization is $214.0M on the latest cached snapshot.
Design Therapeutics Inc (DSGN) cached previous close $12.42; day range $11.78 – $12.52; volume 640,185. Session quote: https://lician.com/quote/dsgn
Design Therapeutics Inc (DSGN) latest cached earnings event is "DSGN earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached DSGN filing is 8-K · Aug 3, 2026. Filings: https://lician.com/sec/dsgn